Literature DB >> 19459017

Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.

Theresa P Yeo1, Ralph H Hruban, Jonathan Brody, Kieran Brune, Sheila Fitzgerald, Charles J Yeo.   

Abstract

INTRODUCTION: Pancreatic cancer (PC) is the fourth leading cause of cancer death in the United States. This study characterizes one of the largest national registries of familial PC (FPC) and sporadic PC (SPC), focusing on demographics, clinical factors, self-reported environmental and occupational lifetime exposures, and survival status.
BACKGROUND: Reported risk factors for PC include advancing age, a family history of PC, high-risk inherited syndromes, cigarette, cigar, and pipe smoking, exposure to occupational and environmental carcinogens, African-American race, high fat/high cholesterol diet, obesity, chronic pancreatitis, and diabetes mellitus. PATIENTS AND METHODS: This retrospective cross-sectional, case-only analysis includes cases of FPC (n = 569) and SPC (n = 689) from the Johns Hopkins National Familial Pancreas Tumor Registry (NFPTR) enrolled between 1994 and 2005.
RESULTS: FPC smokers with environmental tobacco smoke (ETS) exposure were diagnosed at a significantly younger mean age (63.7 years) as compared to FPC non-smokers without ETS exposure (66.6 years; p = 0.05). Non-smoker ETS-exposed cases were diagnosed with PC at a significantly younger mean age (64.0 years) compared to non-smoker non-ETS-exposed cases (66.5 years) (p < 0.0004). The mean age at diagnosis for Ashkenazi Jewish SPC subjects was significantly younger (by 2.1 years) than Ashkenazi Jewish FPC cases (p = 0.05). In addition, Ashkenazi Jewish FPC subjects who smoked were diagnosed 5.9 years earlier than Ashkenazi Jewish FPC non-smokers (p = 0.05). The median length of survival for unresected FPC cases was significantly shorter (168 days) as compared to unresected SPC cases (200 days) (p = 0.04). Survival was improved in resected cases, 713 days for FPC cases and 727 days for SPC cases, but was not significantly different between the groups (p = 0.4). Mild to moderate multiplicative interaction was found between a family history of PC and exposure to asbestos, environmental radon, and environmental tobacco smoke (ETS), as evidenced by odds ratios >1.0.
CONCLUSIONS: These are the first data to show that occupational and environmental exposures may act synergistically with inherited or acquired genetic polymorphisms, resulting in earlier occurrence of PC. Exposure to cigarette smoking and ETS exposure in non-smokers when younger than 21 years of age are associated with a younger mean age of diagnosis in FPC and SPC cases and Ashkenazi Jewish smokers, when compared to non-exposed cases. Risk prediction models which take into account environmental exposures as well as family history may more accurately predict the risk of PC. High-risk individuals will likely benefit from early identification of pre-malignant lesions and molecular profiling, as methods of early detection, prevention, and personalized therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19459017     DOI: 10.1007/s11605-009-0923-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  Occupational exposure to pesticides and pancreatic cancer.

Authors:  B T Ji; D T Silverman; P A Stewart; A Blair; G M Swanson; D Baris; R S Greenberg; R B Hayes; L M Brown; K D Lillemoe; J B Schoenberg; L M Pottern; A G Schwartz; R N Hoover
Journal:  Am J Ind Med       Date:  2001-01       Impact factor: 2.214

Review 2.  Epidemiology of environmental tobacco smoke exposure.

Authors:  Ross C Brownson; Larry W Figgs; Laura E Caisley
Journal:  Oncogene       Date:  2002-10-21       Impact factor: 9.867

3.  Environmental tobacco smoke and risk of adult leukemia.

Authors:  Khaled Kasim; Patrick Levallois; Belkacem Abdous; Pierre Auger; Kenneth C Johnson
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

4.  Comparative carcinogenicity of cigarette mainstream and sidestream smoke condensates on the mouse skin.

Authors:  E Mohtashamipur; A Mohtashamipur; P G Germann; H Ernst; K Norpoth; U Mohr
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 5.  Genetics of pancreatic cancer. From genes to families.

Authors:  R H Hruban; G M Petersen; P K Ha; S E Kern
Journal:  Surg Oncol Clin N Am       Date:  1998-01       Impact factor: 3.495

6.  Occupational exposures and pancreatic cancer: a meta-analysis.

Authors:  I A Ojajärvi; T J Partanen; A Ahlbom; P Boffetta; T Hakulinen; N Jourenkova; T P Kauppinen; M Kogevinas; M Porta; H U Vainio; E Weiderpass; C H Wesseling
Journal:  Occup Environ Med       Date:  2000-05       Impact factor: 4.402

7.  Cigarette smoking and pancreas cancer: a case-control study based on direct interviews.

Authors:  D T Silverman; J A Dunn; R N Hoover; M Schiffman; K D Lillemoe; J B Schoenberg; L M Brown; R S Greenberg; R B Hayes; G M Swanson
Journal:  J Natl Cancer Inst       Date:  1994-10-19       Impact factor: 13.506

Review 8.  Epidemiology and prevention of pancreatic cancer.

Authors:  Albert B Lowenfels; Patrick Maisonneuve
Journal:  Jpn J Clin Oncol       Date:  2004-05       Impact factor: 3.019

9.  Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk.

Authors:  Robert R McWilliams; William R Bamlet; Julie M Cunningham; Ellen L Goode; Mariza de Andrade; Lisa A Boardman; Gloria M Petersen
Journal:  Cancer Res       Date:  2008-06-10       Impact factor: 12.701

Review 10.  Epidemiologic and etiologic factors of pancreatic cancer.

Authors:  Albert B Lowenfels; Patrick Maisonneuve
Journal:  Hematol Oncol Clin North Am       Date:  2002-02       Impact factor: 3.722

View more
  12 in total

1.  Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancer.

Authors:  Joshua G Barton; Thomas Schnelldorfer; Christine M Lohse; William R Bamlet; Kari G Rabe; Gloria M Petersen; John H Donohue; Michael B Farnell; Michael L Kendrick; David M Nagorney; Kay M Reid Lombardo; Florencia G Que
Journal:  J Gastrointest Surg       Date:  2011-02-26       Impact factor: 3.452

Review 2.  Screening for Pancreatic Cancer.

Authors:  Saowanee Ngamruengphong; Marcia Irene Canto
Journal:  Surg Clin North Am       Date:  2016-12       Impact factor: 2.741

Review 3.  Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.

Authors:  Hiroyuki Matsubayashi
Journal:  J Gastroenterol       Date:  2011-08-17       Impact factor: 7.527

Review 4.  Current status of inherited pancreatic cancer.

Authors:  Marek Olakowski; Łukasz Bułdak
Journal:  Hered Cancer Clin Pract       Date:  2022-06-27       Impact factor: 2.164

5.  Genome-wide investigation of gene-environment interactions in colorectal cancer.

Authors:  Sabine Siegert; Jochen Hampe; Clemens Schafmayer; Witigo von Schönfels; Jan-Hendrik Egberts; Asta Försti; Bowang Chen; Jesús Lascorz; Kari Hemminki; Andre Franke; Michael Nothnagel; Ute Nöthlings; Michael Krawczak
Journal:  Hum Genet       Date:  2012-11-02       Impact factor: 4.132

6.  Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma.

Authors:  R Lochan; A K Daly; H L Reeves; R M Charnley
Journal:  J Oncol       Date:  2011-04-06       Impact factor: 4.375

7.  The role of tobacco-derived carcinogens in pancreas cancer.

Authors:  Rajiv Lochan; Helen L Reeves; Anne K Daly; Richard M Charnley
Journal:  ISRN Oncol       Date:  2011-07-17

8.  Serum monocyte chemoattractant protein-1 in pancreatic cancer.

Authors:  Jennifer Sullivan; Qiaoke Gong; Terry Hyslop; Harish Lavu; Galina Chipitsyna; Charles J Yeo; Hwyda A Arafat
Journal:  J Oncol       Date:  2011-10-01       Impact factor: 4.375

Review 9.  Familial pancreatic cancer: Concept, management and issues.

Authors:  Hiroyuki Matsubayashi; Kyoichi Takaori; Chigusa Morizane; Hiroyuki Maguchi; Masamichi Mizuma; Hideaki Takahashi; Keita Wada; Hiroko Hosoi; Shinichi Yachida; Masami Suzuki; Risa Usui; Toru Furukawa; Junji Furuse; Takamitsu Sato; Makoto Ueno; Yoshimi Kiyozumi; Susumu Hijioka; Nobumasa Mizuno; Takeshi Terashima; Masaki Mizumoto; Yuzo Kodama; Masako Torishima; Takahisa Kawaguchi; Reiko Ashida; Masayuki Kitano; Keiji Hanada; Masayuki Furukawa; Ken Kawabe; Yoshiyuki Majima; Toru Shimosegawa
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

10.  Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age.

Authors:  David T Chao; Nilesh H Shah; Herbert J Zeh; Aatur D Singhi; Nathan Bahary; Kevin M McGrath; Kenneth E Fasanella; Amer H Zureikat; David C Whitcomb; Randall E Brand
Journal:  Gastroenterol Res Pract       Date:  2018-06-05       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.